The Anti-LEMD3 Antibody (HPA025078) cataloged by Atlas Antibodies is a rabbit polyclonal antibody targeting human LEMD3 (LEM Domain-Containing Protein 3). LEMD3 is a nuclear envelope protein involved in TGF-β signaling regulation and musculoskeletal development .
| Property | Detail |
|---|---|
| Target Species | Human |
| Validation Methods | IHC, Western Blot (Enhanced) |
| Concentration | 0.2 mg/ml |
| Applications | Research use only |
The term "LEM-3" in scientific literature (e.g., C. elegans studies) refers to LEM-3/Ankle1, a nuclease resolving chromatin bridges during cell division[1-4]. This protein is distinct from human LEMD3.
While no direct data exists for a "LEM3 Antibody" targeting LEM-3/Ankle1, studies in C. elegans elucidate its critical roles:
Chromatin Bridge Resolution: LEM-3 localizes to the midbody during cytokinesis, processing DNA bridges from replication errors or unresolved recombination intermediates .
Meiotic Recombination: LEM-3 cooperates with MUS-81 and SLX-4 nucleases to resolve recombination intermediates, ensuring proper chromosome segregation .
Regulation: AIR-2/Aurora B kinase modulates LEM-3’s midbody localization and activity .
The Anti-LEMD3 Antibody (HPA025078) has been validated for:
Immunohistochemistry (IHC): Detects LEMD3 in human tissue sections.
Western Blot (WB): Identifies ~75 kDa band corresponding to LEMD3 .
No peer-reviewed studies using this antibody are cited in the provided sources.
Cross-reactivity with other LEM-domain proteins remains unverified.
Nomenclature Clarity: "LEM3 Antibody" may cause confusion between LEM-3/Ankle1 (nuclease) and LEMD3 (nuclear envelope protein).
Research Needs: Antibodies specific to LEM-3/Ankle1 are not described in the provided sources, highlighting a gap in tool availability for studying this nuclease.
KEGG: sce:YNL323W
STRING: 4932.YNL323W